New research may have found a more efficient way of treating patients who suffer from PTSD: by using MDMA, which is ecstasy in its purest form. The assisted drug treatment could be approved by the FDA.
“The medicine allows them to look at things from a different place and reclassify them. Honestly, we don’t have to do much. Each person has an innate ability to heal. We just create the right conditions.”
— Ann Mithoefer, psychiatric nurse
MDMA, the pure form of ecstasy, will be employed in treating . The drug is also tested for its properties when it comes to treating terminally ill patients.
The tests conducted for possible have had positive outcomes and researchers consider the approval of MDMA as a prescription drug sometime in the near future.
The first two studies treated patients for 12 weeks, in the form of psychotherapy sessions and MDMA sessions. The MDMA sessions lasted eight hours each, during which the . After being given the drug, the patients would sit in a relaxing environment, surrounded by chill music, flowers and candles in order to suggest a calm state of mind to balance the euphoric effects of the drug. Read the rest of this entry »
An increasing number of twenty-somethings are reportedly ‘micro-dosing’ on psychedelic drugs – and they say it’s making them better workers.
Could taking LSD at work make your more productive?
“You’re doing a task you normally couldn’t stand for two hours, but you do it for three or four. You eat properly. Maybe you do one more set of reps. Just a good day. That seems to be what we’re discovering.”
— Dr James Fadiman, psychedelics researcher
Adam Boult reports: It seems unlikely, but that’s apparently what some Silicon Valley professionals have been doing – and reporting great results.
According to Rolling Stone, a growing number of people are experimenting with “microdoses” of psychedelics to help them work.
A microdose of LSD is around 10-15 micrograms, approximately a tenth of a “normal” dose.
“You’re doing a task you normally couldn’t stand for two hours, but you do it for three or four. You eat properly. Maybe you do one more set of reps. Just a good day. That seems to be what we’re discovering.”
At that dosage, Rolling Stone describes the drug’s effects as “subperceptual”: ” ‘Enough, says Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies, ‘to feel a little bit of energy lift, a little bit of insight, but not so much that you are tripping.’”
Psychedelics researcher Dr James Fadiman discussed microdosing with Vice, saying: ‘People do it and they’re eating better, sleeping better, they’re often returning to exercise or yoga or meditation. It’s as if messages are passing through their body more easily.”
“But what many people are reporting is, at the end of the day, they say, ‘That was a really good day.’ You know, that kind of day when things kind of work.” Read the rest of this entry »
In Switzerland, Canada, Brazil, Peru, Mexico and the United States, researchers with no evident countercultural tendencies are conducting research that is finding psychedelic drugs a valuable adjunct to psychotherapy in treating addiction, post-traumatic stress and the depression or anxiety that often comes with terminal illness.
Melissa Healy reports: New research on the use of psychedelic drugs as treatment for a range of mental disorders appears to be throwing open doors of perception long closed within the medical community, says a new analysis in the Canadian Medical Assn. Journal.
“Experimental therapeutic uses of psychedelic drugs have been tightly controlled, requiring extensive screening of prospective patients, close monitoring during medication use, and extended follow-up.”
For several decades, the North American medical establishment has classified psychedelic drugs — including lysergic acid diethylamide (LSD), psilocybin and methylenedioxymethamphetamine (MDMA) — as drugs of abuse with little to no medical purpose or means of safe use.
“But for all of that, when psychedelics such as MDMA have been tested in conjunction with psychotherapy for PTSD, or psilocybin for alcohol dependence, ‘relatively time-limited interventions’ have been shown to have enduring benefits.”
In Switzerland, Canada, Brazil, Peru, Mexico and the United States, researchers with no evident countercultural tendencies are conducting research that is finding psychedelic drugs a valuable adjunct to psychotherapy in treating addiction, post-traumatic stress and the depression or anxiety that often comes with terminal illness.
“It’s been a cautious road, but one that’s data-driven. A big factor is really that enough time has passed for the sensationalism to kind of simmer down and for sober heads to say, ‘Hold on, let’s look at the evidence.'”
While most are small-scale pilot studies, larger trials are planned — and “more and more people are becoming interested and even jumping into the field to start trials themselves,” said senior author Matthew W. Johnson, a professor of psychiatry and behavioral sciences at Johns Hopkins University. Read the rest of this entry »
Alexis Stigmore had to endure 40 harrowing minutes of class in a distressed state, forced to look at the world through the eyes of a set of people she disagreed with. Now there is a safe space dedicated in her honor.
LYNNFIELD, MA—In an effort to provide sanctuary for Lynnfield College students exposed to perspectives different from their own, a new campus safe space was dedicated Wednesday in honor of Alexis Stigmore, a 2009 graduate who felt kind of weird in class one time.
“When our Alexis felt weird after hearing someone discuss an idea that did not conform to her personally held beliefs, she had no place to turn.”
Addressing students at the dedication ceremony, parents Arnold and Cassie Stigmore noted that while the college had adequate facilities to assist victims of discrimination, abuse, and post-traumatic stress, it had until now offered no comparable safe space for students, like their beloved daughter, who encounter an academic viewpoint that gives them an uncomfortable feeling.
“If unfamiliar thoughts are ever provoked in your mind, or in the mind of someone you know, you can come to this place and feel safe again.”
“When our Alexis felt weird after hearing someone discuss an idea that did not conform to her personally held beliefs, she had no place to turn,” said Arnold Stigmore, standing outside the $2 million space that reportedly features soothing music, neutral-colored walls, oversized floor cushions, fun board games, and a variety of snacks. “God forbid any of you, in your years at this institution, are ever confronted with an opinion you do not share. But if you are, you will have a refuge on this campus.”
“As a parent, I’ll always wish I could have been there for her in that lecture hall, protecting her from those unwelcome concepts.”
“If unfamiliar thoughts are ever provoked in your mind, or in the mind of someone you know, you can come to this place and feel safe again,” he added. Read the rest of this entry »
The Multidisciplinary Association for Psychedelic Studies (MAPS) is attempting to legalize MDMA as a prescription for certain illnesses. In a newsletter sent to their constituents on March 16, MAPS said it had received approval from the United States Drug Enforcement Agency (DEA) on Friday, March 13 for a Schedule I license for Phil Wolfson, M.D., the principal investigator in a new MAPS study. This isn’t the only time the license has been awarded to MAPS — this is currently the seventh MDMA clinical trial with DEA approval.
“MDMA reduces activity in the amygdala where fear is processed and it increases activity in the frontal cortex where people put things in association and context. So people are able to look at traumatic memories.”
“Obtaining DEA approval was the last step in the complex, arduous, and lengthy
process of getting approval for our study,” Dr. Wolfson said in the newsletter.
This was the final step before initiating experiments regarding the safety and effectiveness of MDMA-assisted psychotherapy to treat anxiety associated with life-threatening illnesses. MAPS had already received approval from the Institutional Review Board, FDA and the Research Advisory Panel of California to conduct the phase-2 study.
“They’re able to separate out that it was happening then and not now. We’re saying that MDMA itself is not the medicine. It’s MDMA-assisted psychotherapy.”
Connor McKay, president of the Students for Sensible Drug Policy chapter at Northeastern, said this type of scientific research works against the stigma associated with psychedelics. McKay will also be welcoming the founder of MAPS, Rick Doblin, and former Washington Post Editor Tom Shroder, author of “Acid Test: LSD, Ecstasy, and the Power to Heal,” to Northeastern on April 3 to discuss psychedelic research.
“I think studies like this play an important role…both medical and personal. It gives a personal story to these treatments. It gives medical legitimacy to these substances.”
“I think studies like this play an important role … both medical and personal. It gives a personal story to these treatments. It gives medical legitimacy to these substances,” McKay said. “I don’t think people are going to stop using MDMA recreationally. I think people will see it as abusing medicine … rather than ‘you’re just doing drugs.’ This will open the medical discussion about these substances.”
MDMA, chemically called 3,4-Methylenedioxy-methamphetamine, is typically sold as ecstasy or molly, but these can contain adulterants or other substances. In a 2006 study by Vanderbilt University, only 39 percent of tablets sold as ecstasy were pure and 46 percent had no MDMA at all. Read the rest of this entry »
“Ladies and gentleman, that is not insanity. That is just cold, calculated capital murder. He is guilty of capital murder. He is not in any way insane.”
— Attorney Jane Starnes during closing arguments
A jury has found Eddie Ray Routh guilty of capital murder in the deaths of two men, including Chris Kyle, the author of the bestselling book “American Sniper.” He was immediately sentenced to life in prison without the possibility of parole.
[Previous story, posted at 10:17 p.m. ET]
A verdict has been reached in the trial of the man accused of killing Chris Kyle, subject of the hit film “American Sniper,” and Kyle’s friend at a Texas firing range two years ago.
The reading of the verdict is expected to begin soon. The jury began deliberations at 7:36 p.m. ET.
No one disputes that Eddie Ray Routh shot and killed the men. But defense attorneys say Routh was insane.
Prosecutors dismiss that claim outright.
“Ladies and gentleman, that is not insanity. That is just cold, calculated capital murder. He is guilty of capital murder. He is not in any way insane,” said attorney Jane Starnes during closing arguments.
She claimed Routh knew the difference between right and wrong.
Starnes urged jurors to “follow the law,” allowing the law to guide them “to the true and correct verdict.”
For its part, the defense pointed to Routh’s long history of mental illness.
“He killed those men because he had a delusion. He believed in his mind that they were going to kill him,” said attorney J. Warren St. John.
Routh’s trial comes in the wake of the release of the film about Kyle, a former Navy SEAL who claimed to be the deadliest sniper in U.S. history, with 160 confirmed kills in Iraq. Read the rest of this entry »
Little is known about Routh, except that attorney J. Warren St. John will attempt to make the case that his client is not guilty by reason of insanity
Since being diagnosed with post-traumatic stress disorder in July 2011, her son had been in and out of Veterans Affairs clinics, she said. He showed no progress in two years, and his erratic behavior continued to spiral out of control.
Jodi Routh worked as an aide at the same Midlothian, Texas, elementary school that Chris Kyle’s children attended. Kyle, of course, wrote “American Sniper,” the basis for the blockbuster Clint Eastwood film, and she had heard that The New York Times bestselling author worked with fellow veterans who were having a hard time adjusting to life back home.
“Shortly after his apprehension, Routh confessed to authorities and family members that he killed both men. After becoming aggressive with guards and refusing to give up a spork and dinner tray, he was placed on suicide watch under 24-hour surveillance in the Erath County Jail.”
After the deaths of Kyle and his friend, Chad Littlefield, Beil, who also is a contributing editor for Men’s Health magazine, spent almost four months with Eddie Routh’s family detailing the Marine’s struggles after serving in Iraq and Haiti.
“At the end of the conversation, (Kyle) said, ‘I’m going to do everything I can to help your son.’ She actually cried at that point because it was the first time in over a year that anyone had said that,” Beil told CNN.
Eddie Ray Routh, 27, grew up in the Dallas suburb of Lancaster, about 20 miles east of Midlothian, Kyle’s hometown. He faces murder charges in the 2013 deaths of Kyle, 38, and Littlefield, 35.
The two men had picked Routh up that fateful day and, as a form of therapy, took him to a remote 11,000-acre resort with a gun range in Glen Rose, Texas. Read the rest of this entry »
In an interview with The Daily Beast, author Tom Shroder explains why psychedelics are so important to veterans, and the roadblocks researchers face getting it to them.
Abby Haglage writes: LSD, an illicit drug with a serious stigma, was once the darling of the psychotherapy world.Synthesized by Swiss chemist Albert Hofmann in 1938, the two decades following its birth were populated with study after study showing positive effects. With its ability to reduce defensiveness, help users relive early experiences, and make unconscious material accessible, it proved tremendously successful in therapy.
Senate Majority leader Harry Reid, nearing retirement, is rumored to be using LSD regularly. Seen here is one of Reid’s characteristic pauses to observe chem trails from his undulating hand during a floor speech
In a plethora of studies from the 1950s, researchers found the drug, and other psychedelics in its family, to be successful in treating victims of psychosomatic illnesses ranging from depression to addiction. With fear and hesitation stripped away, psychologists could help their patients dive headfirst into a painful memory, feeling, or thought, and work through it. For some, it sped up a process of awakening that may have taken years. For others, it opened a door that may never have been found otherwise.
But with the widespread recreational use of LSD beginning the 1960s, came both fear from both the general public and the government. After 1970 (when LSD was put on the schedule 1 substance list) it wasn’t technically illegal to do research with psychedelics but rather virtually impossible, given the professional and regulatory hurdles.
More than 40 years later, the criminalization of Hofmann’s drug still persists. The means and approval to research the psychedelic on humans is few and far between. The freedom of sufferers who may benefit to access it is all but nonexistent.
Nowhere are the negative effects of psychedelics’ fate more pronounced than in the story of America’s veterans. Of the many illnesses for which the psychedelic-assisted therapy showed promise, Post-Traumatic Stress Disorder was one of the most profound.
An estimated 500,000 Iraq-Afghanistan military veterans are suffering from PTSD, an excruciating illness that is believed to fuel the estimated 20 suicides that result from that demographic per day. In FDA sanctioned studies using MDMA-assisted therapy to treat veterans with PTSD, the success rate has been astounding. Why has no one noticed? Read the rest of this entry »
Annie Sneed reports: The U.S. has sent thousands of soldiers into combat over the past decade or so, and a good number of them have returned home with deep psychological scars. Up to 20 percent of Afghanistan and Iraq war veterans suffer from post-traumatic stress disorder, or PTSD, according to some expert estimates. Now researchers at The Picower Institute for Learning and Memory at Massachusetts Institute of Technology have found a class of drugs that show promise for helping to heal traumatic memories.
Psychologists often treat PTSD using behavioral therapy, a method that encourages patients to confront stressful memories and then replace those recollections with new, nontraumatic ones. But the technique is not always effective. Li-Huei Tsai and her colleagues tested drugs that they predicted might make a patient’s memories more responsive to therapy. The researchers targeted old and new traumatic memories in mice with drugs called histone deacetylase (HDAC) inhibitors, which increase the plasticity of the brain’s learning and memory areas. They found that HDAC, in combination with behavioral therapy, eased the burden of both recent and old stressful memories in mice, whereas behavioral therapy alone only helped mice suffering from recent trauma.
SEATTLE – The man identified by Washington D.C. police as a suspect in this morning’s shooting at a U.S. Navy Yard was arrested in Seattle in 2004 after an incident that he later described to police as an anger-fueled “blackout.”
Seattle Police say Aaron Alexis was arrested June 3rd 2004, a few days after shooting out the tires of a car parked in a driveway next to a home where he was staying in the Beacon Hill neighborhood.
Police say the morning of May 6th 2004, construction workers reported a man coming out of a house near where they were working and shooting out the tires of a Honda Accord that they had driven to the site and then returning to a nearby home.
Initially police say they couldn’t find the shooter, but a couple of days later they were able to track him down and arrest him outside his home. Once they searched that home, police say they found a gun and ammunition in Alexis’ room. Alexis was booked into the King County Jail for malicious mischief. Read the rest of this entry »
never have been found otherwise.
